-PTI NEW DELHI: A global study on a range of health indicators released on Thursday has ranked India 143rdamong 188 countries, citing various challenges, including mortality rates, malaria, hygiene and air pollution. "Despite rapid economic growth, India was ranked below Comoros and Ghana," the first annual assessment of Sustainable Development Goals (SDG) health performance published in medical journal Lancet and launched at a special event at the United Nations general assembly in...
More »SEARCH RESULT
Total Matching Records found : 2606
No fingers? No monthly ration -ASRP Mukesh
-The Telegraph Ranchi: The Aadhaar-enabled public distribution system (PDS) launched in Ranchi on pilot basis threw up a tragic loophole today when around 50 leprosy patients turned up at their ward councillor's office, saying they had not received ration for the past three months as they lacked thumbs and fingers to verify their biometric identity. The 50-odd leprosy patients, including women, told ward 43 councillor Chanda Devi their very survival was at...
More »Kejriwal government under attack over Chikungunya deaths in Delhi
-The Times of India NEW DELHI: With chikungunya and dengue deaths in the national capital on the rise, the Arvind Kejriwal-led AAP government in Delhi has come under severe opposition attack. As the number of deaths due to chikungunya rose to three on Tuesday, the Congress and the BJP attacked the Kejriwal government for doing little . Two more people died of chikungunya in Delhi on Tuesday, taking the toll from the mosquito-borne...
More »Poor sanitation cost India 5.2% of its GDP -Sushmita Sengupta
-Down to Earth Lack of access to sanitation wiped off US $106.7 billion from India's GDP in 2015. It is almost half of the total global losses A report—True cost of sanitation—was published jointly by the LIXIL Group Corporation, Water Aid and Oxford Economics recently. Oxford Economics mainly works on economic forecasting and modelling. It says that in 2015 lack of access to sanitation cost the global economy around US $ 222.9...
More »Indian generics bringing down global price of hepatitis C drugs, finds WHO -Himani Chandna
-Hindustan Times India’s generic drug manufacturers have flooded the market with cheaper medicines to treat hepatitis C after Gilead Sciences Inc’s patent application was rejected in January 2015. Thanks to domestic drugmakers, the world is looking to India to reduce the price of hepatitis C drug further. “By scaling up the production of generic medicines, India is playing a pivotal role globally in reducing the prices of medicines for hepatitis C,” said Henk...
More »
